Y-Biologics, Inc. (KOSDAQ:338840)
South Korea · Delayed Price · Currency is KRW 13,550
+450 (3.44%)
At close: Jun 11, 2026
Y-Biologics Market Cap
Y-Biologics has a market cap or net worth of 212.34 billion as of June 12, 2026. Its market cap has increased by 82.06% in one year.
Market Cap
212.34B
Enterprise Value
186.80B
Revenue
2.79B
Ranking
n/a
PE Ratio
n/a
Stock Price
13,550.00
Market Cap Chart
Since December 5, 2023, Y-Biologics's market cap has increased from 177.50B to 212.34B, an increase of 19.63%. That is a compound annual growth rate of 7.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 212.34B | -38.91% |
| Dec 30, 2025 | 347.58B | 205.76% |
| Dec 30, 2024 | 113.68B | -50.64% |
| Dec 28, 2023 | 230.30B | 29.75% |
| Dec 5, 2023 | 177.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genome & Company | 259.75B |
| Kanaph Therapeutics | 244.31B |
| curacle co.,ltd. | 240.10B |
| Kangstem Biotech | 232.31B |
| NIBEC | 208.03B |
| ViGenCell | 190.85B |
| Bio Solution | 181.15B |
| TiumBio | 169.12B |